Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 trial comparing NVA237 to placebo in chronic obstructive pulmonary disease and notes that the results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• NVA237

Snippet

Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-04-12